Advertisement
Perspective

Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

Should We Include Connection Domain Mutations of HIV-1 Reverse Transcriptase in HIV Resistance Testing?

  • Published: December 01, 2007
  • DOI: 10.1371/journal.pmed.0040346

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

N348I in the Connection Domain of HIV-1 Reverse Transcriptase Confers Zidovudine and Nevirapine Resistance

Soo-Huey Yap, Chih-Wei Sheen, Jonathan Fahey, Mark Zanin, David Tyssen, Viviane Dias Lima, Brian Wynhoven, Michael Kuiper, Nicolas Sluis-Cremer, P. Richard Harrigan, Gilda Tachedjian
Research Article | published 1 Dec 2007 | PLOS Medicine
doi:10.1371/journal.pmed.0040335

HIV Treatment Proceeds as Prevention Research Confounds

Editorial | published 1 Dec 2007 | PLOS Medicine
doi:10.1371/journal.pmed.0040347